Purpose. A positive resection margin (RM+) is acknowledged as a poor prognostic factor after gastrectomy. Microsatellite instability (MSI-H) gastric cancer has been identified as a subgroup of gastric cancer that may be associated with an improved prognosis. The aim of the study was an analysis of MSI status on patients with margin involvement after gastrectomy and examination of the association between MSI, margin status, and survival outcomes. Methods. From a large prospectively annotated surgical database we collected clinicopathological and survival data on patients who had undergone a potentially curative resection for gastric cancer. MSI status was assessed using a standard 5-marker quasi-monomorphic mononucleotide repeat panel. Patie...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
PURPOSE In the CLASSIC and MAGIC trials, microsatellite instability (MSI)-high status was a favorabl...
Background: Several associations between microsatellite instability (MSI) and other clinicopathologi...
Purpose. A positive resection margin (RM+) is acknowledged as a poor prognostic factor after gastrec...
Purpose. A positive resection margin (RM+) is acknowledged as a poor prognostic factor after gastrec...
BACKGROUND: The assessment of microsatellite instability (MSI) is not included yet in the routine ...
BACKGROUND: The assessment of microsatellite instability (MSI) is not included yet in the routine ...
BACKGROUND: The assessment of microsatellite instability (MSI) is not included yet in the routine ...
BACKGROUND AND OBJECTIVE: The relationship between survival in gastric cancer patients and the statu...
Background: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is controve...
We previously reported that the prognosis of microsatellite instability high (MSI-H) gastric cancer ...
This study investigated whether MSI status can be used as a prognostic biomarker and whether it is h...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
PURPOSE In the CLASSIC and MAGIC trials, microsatellite instability (MSI)-high status was a favorabl...
Background: Several associations between microsatellite instability (MSI) and other clinicopathologi...
Purpose. A positive resection margin (RM+) is acknowledged as a poor prognostic factor after gastrec...
Purpose. A positive resection margin (RM+) is acknowledged as a poor prognostic factor after gastrec...
BACKGROUND: The assessment of microsatellite instability (MSI) is not included yet in the routine ...
BACKGROUND: The assessment of microsatellite instability (MSI) is not included yet in the routine ...
BACKGROUND: The assessment of microsatellite instability (MSI) is not included yet in the routine ...
BACKGROUND AND OBJECTIVE: The relationship between survival in gastric cancer patients and the statu...
Background: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is controve...
We previously reported that the prognosis of microsatellite instability high (MSI-H) gastric cancer ...
This study investigated whether MSI status can be used as a prognostic biomarker and whether it is h...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
BACKGROUND: The clinical role of microsatellite instability (MSI) in gastric cancer (GC) is cont...
PURPOSE In the CLASSIC and MAGIC trials, microsatellite instability (MSI)-high status was a favorabl...
Background: Several associations between microsatellite instability (MSI) and other clinicopathologi...